AI assistant
Sending…
Artiva Biotherapeutics, Inc. — Director's Dealing 2025
Jan 29, 2025
34393_dirs_2025-01-29_fab9701c-855e-4526-af39-cdf1e83a78e5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Artiva Biotherapeutics, Inc. (ARTV)
CIK: 0001817241
Period of Report: 2025-01-28
Reporting Person: Baker Daniel G. (N/A)
More from Artiva Biotherapeutics, Inc.
Board/Management Information
2026
May 19
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Board/Management Information
2026
Feb 24
Director's Dealing
2026
Feb 20
Board/Management Information
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19